ARCHIVES

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

This article is from The Cancer Letter archive.

Vol. 10 No. 42 | November 2, 1984

Download PDF Visit The Full Archive

Related Articles

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

NIH Director Collins Challenged On Capitol Hill Over NCI-Funded Research Linking Tea Party With Tobacco Companies

March 8, 2013

CCOP RFA On The Street; Addition Of Cancer Control Research Adds New Dimension To Program

July 18, 1986

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

Staff Advisory Boards To Be Formed; Three BSCs Proposed

August 11, 1995